Want to see JP:4438 full AI Analyst Report?
4438 Stock Chart & Stats
¥279.00
¥1.00(0.29%)
At close: 4:00 PM EST
¥279.00
¥1.00(0.29%)
Day’s Range― - ―
52-Week Range¥231.00 - ¥558.00
Previous CloseN/A
Volume4.50K
Average Volume (3M)3.91K
Market Cap
¥2.17B
Enterprise Value¥2.73K
Total Cash (Recent Filing)¥516.23M
Total Debt (Recent Filing)¥539.39M
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-63.35
Shares Outstanding8,435,582
10 Day Avg. Volume3,070
30 Day Avg. Volume3,910
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)8.48
Price to Sales (P/S)3.63
P/FCF Ratio-6.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained ~71% gross margins indicate strong unit economics and pricing power within its healthcare information services. Over the medium term this supports scalable revenue retention and the potential for operating leverage if fixed costs and SG&A are managed as revenue scales.
2025 Revenue ReboundA ~78% revenue rebound in 2025 demonstrates meaningful demand recovery and market traction after 2024 weakness. If sustained, this growth provides a foundation to improve fixed-cost absorption, expand customer footprint, and move toward positive operating leverage over the next several quarters.
Sizable Asset BaseTotal assets of roughly ¥1.05bn provide a tangible balance-sheet cushion and potential collateral for financing. This asset base can support continued operations, product investment or restructuring options and offers management flexibility while working to stabilize cash flows.
Bears Say
Deep And Persistent LossesNet margin near -85% and ongoing negative operating profit show core operations are not yet profitable. Such deep losses erode equity, limit internal reinvestment capacity, prolong the timeline to sustainable profitability and increase dependence on strategic corrective actions or outside capital.
Negative Operating And Free Cash FlowOperating CFO and FCF remain substantially negative, reflecting continued cash burn despite some improvement. Persistent negative cash generation forces reliance on external financing, shortens runway, constrains investment in growth initiatives and raises vulnerability to tighter capital markets.
Elevated LeverageDebt of ~¥606m and a debt-to-equity ratio near 2.22x mark a material increase in leverage. With weak cash flow and losses, higher leverage elevates refinancing and interest-service risk, restricts strategic flexibility and increases solvency pressure if operating performance does not improve.
4438 FAQ
What was Welby Inc.’s price range in the past 12 months?
Welby Inc. lowest stock price was ¥231.00 and its highest was ¥558.00 in the past 12 months.
What is Welby Inc.’s market cap?
Welby Inc.’s market cap is ¥2.17B.
When is Welby Inc.’s upcoming earnings report date?
Welby Inc.’s upcoming earnings report date is Aug 13, 2026 which is tomorrow.
How were Welby Inc.’s earnings last quarter?
Welby Inc. released its earnings results on May 15, 2026. The company reported -¥18.41 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Welby Inc. overvalued?
According to Wall Street analysts Welby Inc.’s price is currently Overvalued.
Does Welby Inc. pay dividends?
Welby Inc. does not currently pay dividends.
What is Welby Inc.’s EPS estimate?
Welby Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Welby Inc. have?
Welby Inc. has 8,435,582 shares outstanding.
What happened to Welby Inc.’s price movement after its last earnings report?
Welby Inc. reported an EPS of -¥18.41 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.051%.
Which hedge fund is a major shareholder of Welby Inc.?
Currently, no hedge funds are holding shares in JP:4438
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Welby Inc.
Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health conditions, encompassing diabetes mellitus, lifestyle-related diseases, mental health disorders, autoimmune and neurological diseases, rare conditions, oncology, and pain management. Furthermore, Welby is active in medical data surveying and operates its signature platform, Welby My Carte.